DEEPNOID Inc. (KOSDAQ: 315640)

Market Cap	135.65B
Revenue (ttm)	9.28B
Net Income (ttm)	-8.06B
Shares Out	22.42M
EPS (ttm)	-665.25
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	232,126
Average Volume	183,278
Open	6,230.00
Previous Close	6,050.00
Day's Range	6,080.00 - 6,280.00
52-Week Range	4,160.00 - 22,800.00
Beta	0.89
RSI	51.42
Earnings Date	Mar 20, 2025

About DEEPNOID

DEEPNOID Inc. provides medical artificial intelligence solutions. The company offers its solutions under the DEEP:NEURO, DEEP:LUNG, DEEP:SPINE, DEEP:CHEST, DEEP:BREAST, DEEP:ENDO, DEEP:DENTAL, DEEP:FUNDUS, DEEP:PATH, and DEEP LIVER names. Its solutions analyzes clinical data related to diseases, such as medical images, including CT, MRI, X-ray, and pathological images dealing with disease-related cells and tissues, and electronic medical records (EMR) of hospitals. The company was founded in 2008 and is based in Seoul, South Korea.

• Industry: Computer Programming, Data Processing, And Other Computer Related Services
• Founded: 2008
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 315640

Financial Performance

In 2023, DEEPNOID's revenue was 1.93 billion, a decrease of -39.24% compared to the previous year's 3.18 billion. Losses were -6.74 billion, 26.3% more than in 2022.